Viewing StudyNCT01222780

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 10:59 PM
Last Modification Date: 2024-10-26 @ 10:26 AM
Study NCT ID: NCT01222780
Status: COMPLETED
Last Update Posted: 2020-01-18
First Post: 2010-10-15
Brief Title: To Evaluate the Safety Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Sponsor: Acrotech Biopharma Inc
Organization: Acrotech Biopharma Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Brain Tumors
Sarcoma
Neuroblastoma
Wilms Tumor
Leukemia
Lymphoma
Keywords:
Name View
Brain Tumor View
Hematologic Malignancies View
Vincristine Sulfate View
Maximum Tolerated Dose View
Pharmacokinetics View
Solid Tumors View
Cancer View
Pediatrics View
Sarcoma View
Wilms Tumor View
Leukemia View
Lymphoma View